serum aspartate aminotransferase level and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis c
Clicks: 273
ID: 217351
2013
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
30.0
/100
272 views
30 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
BACKGROUND: Hepatitis C virus (HCV) infection remains the leading indication for liver transplantation (LT) worldwide. Recurrent hepatitis C following LT is universal, and significant fibrosis (SF, Metavir fibrosis stage ≥2) apparent on protocol biopsy typically prompts antiviral therapy.
| Reference Key |
tanaka2013canadianserum
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Tomohiro Tanaka;George Therapondos;Nazia Selzner;Eberhard L Renner;Leslie B Lilly |
| Journal | indian journal of pharmacology |
| Year | 2013 |
| DOI |
10.1155/2013/904636
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.